Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Medivation, Inc. is a biopharmaceutical company, which is focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options.
| Name: | Medivation Inc. |
|---|---|
| Address: | 525 Market Street San Francisco, California 94105 |
| Phone: | (415) 543-3470 |
| Email: | NA |
| Web site: | www.medivation.com |
| CEO: | NA |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 72,000 | 67,500 |
| Institutional | 99.48% | NA | NA |
| Change in Short Interest as of 3/15/2013 | -3.48% | ||
| Short Interest as % of Float as of 3/15/2013 | 5.45% | ||
| Number of Employees | 257 |
|---|---|
| Revenue per Employee | $706,988 |
| Income per Employee | $-160,533 |
| Market Capitalization (thousands) | $3,780,330 |
| Enterprise Value (thousands) | $3,396,328 |
| Auditors Opinion | Unqualified |
Officers and Directors
Kim D Blickenstaff, David T Hung, Clarence Patrick Machado, Harry H Mansbach, Lynn Seely, Sarah Noonberg, Mohammad Hirmand, Stewart Hallett, Andria Langenberg, Cheryl L Cohen, Bryan Selby, Vandana Date, Sarvajit Chakravarty, Joyce Mordenti, Gretchen Burke, Kathryn E Falberg, Daniel D Adams, William Anthony Vernon, Anne Bowdidge, Andrew A Protter
